Try our Advanced Search for more refined results

Danco Laboratories, L.L.C., Petitioner v. Alliance for Hippocratic Medicine, et al.

  1. February 01, 2024

    Ex-FDA Leaders Urge High Court To Nix Mifepristone Ruling

    Seven former commissioners and acting commissioners of the U.S. Food and Drug Administration told the U.S. Supreme Court on Thursday that a Fifth Circuit decision reinstating some restrictions on mifepristone, a drug used to end early pregnancies and manage miscarriages, threatens the nation's drug approval process.

  2. January 30, 2024

    Scholars, Advocates Tell Justices Mifepristone Limits Must Go

    A mix of scholars, healthcare providers, lawmakers and abortion rights supporters filed three dozen amicus briefs Tuesday, urging the U.S. Supreme Court to reverse a Fifth Circuit decision that reinstated some restrictions on mifepristone, a drug used to end early pregnancies and manage miscarriages.

  3. January 29, 2024

    Justices To Hear Abortion Drug Case Arguments In March

    The U.S. Supreme Court is set to consider live arguments in a case that could determine the future availability of a widely used abortion medication, advancing a matter some regard as the most significant battle over abortion since the justices overruled Roe v. Wade.

  4. January 24, 2024

    Feds Ask Justices To Nix 5th Circ.'s Abortion Pill Limits

    The Biden administration has asked the U.S. Supreme Court to reverse a Fifth Circuit decision upholding a lower court's reinstatement of restrictions on access to the abortion medication mifepristone, saying that the case marks the first time any court has challenged the scientific judgment of U.S. Food and Drug Administration experts by restricting access to an FDA-approved drug.

  5. January 23, 2024

    Danco Asks Justices To Reject 5th Circ.'s Abortion Pill Limits

    The distributor of Mifeprex, the brand name of the abortion medication mifepristone, urged the U.S. Supreme Court on Tuesday to reverse the Fifth Circuit's decision upholding an "unprecedented" injunction restricting access to the pill, saying anti-abortion groups and other respondents don't have standing to challenge federal approvals of the medication.

  6. January 12, 2024

    Va. Abortion Drug Access Suit Paused For High Court Rulings

    A Virginia federal judge overseeing an abortion providers' suit seeking to prevent the U.S. Food and Drug Administration from revoking access to a long-approved and widely used abortion medication agreed on Friday to stay the proceedings until after the U.S. Supreme Court issues rulings in two cases that bear on the question. 

  7. January 08, 2024

    Supreme Court Is Suddenly Embroiled In A Term For The Ages

    When 2024 began, the U.S. Supreme Court's docket — spanning abortion, guns, social media, the modern regulatory system and more — already seemed certain to shake up the nation's cultural and economic landscapes. But now there's also a showdown involving Donald Trump and America's constitutional bedrock, auguring a truly tectonic term.

  8. January 01, 2024

    5 Supreme Court Cases To Watch This Spring

    "Blockbuster," "momentous" and "historic" are all words that have been used to describe the U.S. Supreme Court's current term as the justices prepare for a spring docket jam-packed with questions over the level of deference courts should give federal agencies, whether and how social media companies should be regulated and whether government efforts to combat misinformation crosses the line between persuasion and coercion.

  9. January 01, 2024

    Appellate Outlook: Circuit Splits & Hot Topics To Track In 2024

    The 2024 appellate almanac is looking lively after eye-popping opinions and arguments in 2023's homestretch. As the new year begins, several circuit splits seem more serious, ideological imbalances are in the spotlight, and luminaries of the U.S. Supreme Court bar are locked in a burgeoning battle over alleged corporate complicity in terrorism.

  10. December 13, 2023

    Supreme Court To Consider Fight Over Abortion Medication

    The U.S. Supreme Court said Wednesday that it would review a dispute over the abortion medication mifepristone, setting up a high court battle over a lower court judge's extraordinary decision to block the U.S. Food and Drug Administration's decades-old approval of the drug.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!